TRIN

Trinity Capital Inc. NASDAQ

Financial Services ·Asset Management ·US · trincapinvestment.com

$16.81

Mkt Cap $1.2B

52w Low $13.75 88.7% of range 52w High $17.20

50d MA $15.14 200d MA $15.37

P/E (TTM) 8.5x

EV/EBITDA 10.7x

P/B 1.1x

Debt/Equity 1.2x

ROE 12.4%

P/FCF -1.9x

RSI (14) —

ATR (14) —

Beta 0.62

50d MA $15.14

200d MA $15.37

Avg Volume 1.4M

About

Trinity Capital Inc. is a business development company. It is a venture capital firm specializing in venture debt to growth stage companies looking for loans and/or equipment financing. Trinity Capital Inc. was founded in 2019 is based in Phoenix, Arizona with additional offices in Lutherville-Timonium, Maryland, San Diego, California and Austin, Texas.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 25, 2026	AMC	0.51	0.52	+2.0%	15.40	+0.1%	-1.3%	-4.0%	-3.2%	-3.2%	-1.9%	-7.2%	—
Nov 5, 2025	AMC	0.52	0.52	+0.0%	14.41	+1.0%	+0.0%	+1.3%	+2.2%	+3.7%	+3.5%	+3.5%	—
Aug 6, 2025	AMC	0.52	0.53	+1.9%	15.33	+0.5%	+1.0%	+3.2%	+2.7%	+3.5%	+5.2%	+5.9%	—
May 7, 2025	AMC	0.53	0.52	-1.9%	13.83	+2.7%	+2.1%	+3.0%	+5.5%	+7.1%	+6.7%	+5.1%	—
Apr 29, 2025	AMC	—	0.72	—	14.70	-0.7%	-1.2%	-3.2%	-2.5%	-3.8%	-4.1%	-0.7%	—
Oct 30, 2024	AMC	0.52	0.54	+3.8%	13.62	-0.1%	+1.2%	-2.0%	-3.7%	-1.8%	+0.4%	+7.7%	—
Aug 7, 2024	AMC	0.52	0.51	-1.9%	14.43	+0.7%	+0.4%	+0.0%	-0.7%	-1.8%	-1.5%	-4.1%	—
May 1, 2024	AMC	0.55	0.52	-5.5%	14.71	+0.0%	-1.6%	-0.5%	+0.7%	+0.8%	+0.8%	+1.4%	—
Mar 6, 2024	AMC	0.55	0.54	-1.8%	14.89	+0.8%	+1.3%	-0.3%	+0.0%	+0.3%	+0.7%	-2.9%	—
Nov 1, 2023	AMC	0.55	0.55	+0.0%	14.29	+0.8%	+2.0%	+2.1%	+0.8%	+0.4%	+1.1%	+3.5%	—
Aug 2, 2023	AMC	0.53	0.61	+15.1%	15.00	+0.7%	+1.9%	-5.9%	-5.5%	-5.7%	-6.3%	-3.0%	—
May 4, 2023	AMC	0.57	0.52	-8.8%	11.78	+2.4%	+0.3%	+0.3%	-0.6%	-0.7%	-1.6%	+9.5%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Oct 14	UBS	Maintains	Buy → Buy	—	$14.83	$14.80	-0.2%	+1.1%	+2.1%	-0.9%	-0.3%	-0.7%
Aug 12	Wells Fargo	Maintains	Underweight → Underweight	—	$15.75	$15.80	+0.3%	+0.8%	+2.3%	+2.3%	+1.3%	+1.1%
Aug 7	B. Riley Securities	Maintains	Buy → Buy	—	$15.33	$15.40	+0.5%	+1.0%	+3.2%	+2.7%	+3.5%	+5.2%
Jul 16	UBS	Maintains	Buy → Buy	—	$14.52	$14.60	+0.6%	+1.9%	+3.1%	+3.1%	+2.1%	+2.8%
May 8	Keefe, Bruyette & Woods	Maintains	Market Perform → Market Perform	—	$13.83	$14.20	+2.7%	+2.1%	+3.0%	+5.5%	+7.1%	+6.7%
Apr 28	Wells Fargo	Maintains	Underweight → Underweight	—	$14.86	$14.83	-0.2%	-0.1%	-1.1%	-2.2%	-4.2%	-3.6%
Apr 17	UBS	Maintains	Buy → Buy	—	$14.13	$14.15	+0.1%	+1.3%	-0.8%	+1.2%	+2.8%	+4.1%
Feb 28	Wells Fargo	Maintains	Underweight → Underweight	—	$16.22	$16.28	+0.4%	+2.1%	+1.4%	-0.4%	-1.2%	-3.0%
Feb 27	Keefe, Bruyette & Woods	Maintains	Market Perform → Market Perform	—	$16.54	$16.65	+0.7%	-1.9%	+0.1%	-0.6%	-2.3%	-3.1%
Dec 2	Wells Fargo	Downgrade	Equal Weight → Underweight	—	$14.67	$14.47	-1.4%	-1.6%	-2.2%	-1.8%	-2.7%	-2.5%
Oct 29	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$13.88	$13.83	-0.4%	-2.1%	-1.9%	-0.7%	-3.8%	-5.5%
May 2	B. Riley Securities	Maintains	Buy → Buy	—	$14.71	$14.71	+0.0%	-1.6%	-0.5%	+0.7%	+0.8%	+0.8%
Mar 18	UBS	Maintains	Buy → Buy	—	$14.80	$14.87	+0.5%	-0.3%	-0.3%	-0.2%	+0.9%	+0.9%
Mar 7	B. Riley Securities	Maintains	Buy → Buy	—	$14.89	$15.01	+0.8%	+1.3%	-0.3%	+0.0%	+0.3%	+0.7%
Aug 22	Compass Point	Upgrade	Neutral → Buy	—	$14.35	$14.58	+1.6%	-1.3%	+1.3%	-0.6%	+0.1%	+0.9%
Aug 17	UBS	Maintains	Buy → Buy	—	$13.98	$13.98	+0.0%	+2.6%	+2.3%	+2.6%	+1.4%	+3.9%
Aug 3	Oppenheimer	Maintains	Outperform → Outperform	—	$15.00	$15.10	+0.7%	+1.9%	-5.9%	-5.5%	-5.7%	-6.3%
Aug 2	B. Riley Securities	Maintains	Buy → Buy	—	$14.58	$14.73	+1.0%	+2.9%	+4.9%	-3.2%	-2.8%	-3.0%
May 8	B. Riley Securities	Maintains	Buy → Buy	—	$11.82	$12.03	+1.8%	+0.0%	-0.9%	-1.0%	-1.9%	-3.6%
May 8	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$11.82	$12.03	+1.8%	+0.0%	-0.9%	-1.0%	-1.9%	-3.6%
Apr 18	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$12.79	$12.73	-0.5%	-2.8%	-3.3%	-4.6%	-5.2%	-6.1%
Mar 13	Keefe, Bruyette & Woods	Downgrade	Market Perform → Underperform	—	$12.40	$12.15	-2.0%	-6.5%	+1.0%	+3.6%	+6.3%	+5.0%
Mar 6	B. Riley Securities	Maintains	Buy → Buy	—	$14.26	$14.50	+1.7%	-1.0%	-1.0%	-1.2%	-5.1%	-13.0%
Mar 3	Keefe, Bruyette & Woods	Maintains	Market Perform → Market Perform	—	$13.39	$14.18	+5.9%	+6.5%	+5.5%	+5.5%	+5.2%	+1.0%
Nov 7	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$11.00	$11.00	+0.0%	+0.5%	-3.6%	-3.6%	-0.5%	+1.1%
Nov 4	Keefe, Bruyette & Woods	Downgrade	Outperform → Market Perform	—	$11.31	$11.10	-1.9%	-2.7%	-2.3%	-6.3%	-6.3%	-3.2%
Oct 28	Compass Point	Downgrade	Buy → Neutral	—	$12.33	$12.28	-0.4%	-2.4%	-3.3%	-1.4%	-4.1%	-8.3%
Oct 27	Compass Point	Downgrade	Buy → Neutral	—	$13.82	$13.75	-0.5%	-10.8%	-13.0%	-13.7%	-12.0%	-14.5%
Oct 24	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$13.30	$13.35	+0.4%	+0.2%	+3.0%	+3.9%	-7.3%	-9.5%
Jul 25	Wells Fargo	Downgrade	Overweight → Equal Weight	—	$14.89	$14.38	-3.4%	-2.3%	-4.3%	-2.8%	-2.1%	-1.1%
May 10	Wells Fargo	Maintains	Overweight → Overweight	—	$15.57	$16.46	+5.7%	+0.6%	-0.4%	-2.2%	-1.7%	+0.1%
Oct 25	Wells Fargo	Maintains	Overweight → Overweight	—	$15.97	$16.00	+0.2%	+1.3%	-0.1%	+0.6%	+2.0%	+1.1%
Aug 9	Wells Fargo	Maintains	Overweight → Overweight	—	$15.25	$15.25	+0.0%	-0.1%	-1.2%	-0.4%	-1.6%	+0.0%
May 7	Ladenburg Thalmann	Upgrade	Neutral → Buy	—	$15.00	$15.03	+0.2%	-0.4%	-0.3%	-2.4%	-3.5%	-4.1%
May 4	Oppenheimer	Maintains	Outperform → Outperform	—	$14.59	$14.60	+0.1%	+0.5%	+1.7%	+2.8%	+2.4%	+2.5%

Recent Filings

8-K · 7.01 ! Medium

Unknown — 8-K 7.01: Regulation FD Disclosure

Trinity Capital's strong $395M commitment growth and $306M funding in Q1 2026 signals robust business momentum and portfolio expansion, supporting revenue visibility and justifying continued investor confidence in the alternative asset manager's growth trajectory.

Apr 10

8-K

Unknown — 8-K Filing

Candel Therapeutics secured $130 million in debt financing, extending its cash runway to advance cancer immunotherapy development, but increasing financial obligations that could dilute shareholders if clinical trials fail.

Mar 12

8-K · 7.01 ! Medium

Trinity Capital Inc. 7.875% Notes due 2029 -- 8-K 7.01: Regulation FD Disclosure

Trinity Capital disclosed its Q4 2025 earnings presentation ahead of its February 25 conference call, providing investors transparency into fourth-quarter and full-year results through regulated disclosure channels.

Feb 25

8-K

Trinity Capital Inc. 7.875% Notes due 2029 -- 8-K Filing

Trinity Capital Inc. reported preliminary fourth quarter and full-year 2025 financial results, providing investors with early earnings guidance ahead of full disclosure, impacting expectations for the company's debt-financed business performance.

Feb 3

Data updated apr 27, 2026 5:35am · Source: massive.com